Full-Time

Research Associate I

Genomics and Next Generation Sequencing

Posted on 4/19/2024

Scribe Therapeutics

Scribe Therapeutics

51-200 employees

Develops CRISPR-based genetic medicine platforms

Biotechnology

Entry

Alameda, CA, USA

Required Skills
Communications
Data Analysis
Requirements
  • Degree in molecular biology, bioengineering, genetics, biochemistry or a related field
  • Experience working in an academic or industry lab, including hands-on experience with NGS based assays and high-throughput automated liquid handling platforms
  • Proficient with molecular genetics wet-lab techniques, particularly PCR, qPCR, ddPCR, and NGS library preparation (Amplicon sequencing, RNA-Seq, epigenomic sequencing assays, long-read sequencing)
  • Hands-on experience operating and maintaining Illumina, PacBio, and/or Oxford Nanopore sequencing platforms
  • Collaborative experience working with Computational Biologists, Biostatisticians, and Data Scientists to define data analysis approaches
  • Inquisitive nature and a willingness to continuously learn about new areas of science and biotechnology, regardless of prior background in these domains. Demonstrated quantitative and scientific thinker as evidenced by a strong publication record
  • Exemplify our values of integrity, creativity, drive and pragmatism
  • Excellent interpersonal and communication skills with a demonstrated ability to work effectively in a team environment
Responsibilities
  • Work closely across teams to generate high throughput sequencing data sets for their projects
  • Design and execute hypothesis-driven and properly controlled studies, analyze data with rigorous statistics, and write up publication quality reports
  • Effectively collaborate with members within a fully integrated team to facilitate execution on projects within established timelines
  • Contribute to novel assay development across sequencing platforms to expand Scribe’s NGS technology platform
  • Effectively present updates, and communicate research plans and timelines to the senior leadership team
  • Ability to work both independently and collaboratively in a fast-paced, interdisciplinary research team

Scribe Therapeutics is engaged in pioneering advancements in genetic medicine, utilizing CRISPR-based technologies aimed at precise genome editing and specific targeting. Their focus on innovative delivery technologies and commitment to achieving exceptional specificity within the genome positions them as a leader in the biotechnology field. This commitment to cutting-edge science and precise therapeutic impacts offers a stimulating environment for professionals passionate about genetic research and development.

Company Stage

Series B

Total Funding

$140.2M

Headquarters

Alameda, California

Founded

2017

Growth & Insights
Headcount

6 month growth

6%

1 year growth

22%

2 year growth

119%